Patients who took the drug, Repatha, were significantly less likely to have heart attacks or strokes, researchers concluded. But its high cost will be an issue.
GINA KOLATA, NY Times: Science
Fri, 03/17/2017 - 6:00am
Patients who took the drug, Repatha, were significantly less likely to have heart attacks or strokes, researchers concluded. But its high cost will be an issue.